Anbio Biotechnology

NNNN

NASDAQMedical Instruments & Supplies

+456.2%

since IPO

IPO Price

$5.00

Current Price

$27.81

Return

+456.2%▲

Market Cap

$1.2B

IPO Date

Feb 19, 2025

Lockup End

Aug 18, 2025

Lockup Status

Lockup expired 254days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price

IPO Price

Lockup End

Performance Summary

First Day

N/A

1 Month

N/A

3 Months

N/A

6 Months

N/A

1 Year

N/A

Since IPO

+456.2%

Anbio Biotechnology (NNNN) — IPO Analysis

By Kian O Connor | Updated 4/29/2026

Company Overview

Anbio Biotechnology (ticker: NNNN) specializes in surgical instrument innovation while maintaining strategic capabilities in respiratory care equipment, positioning itself within the Medical Instruments & Supplies sector through training efficiency and specialized service delivery. The company has developed its operations around cost-effective solutions, creating market differentiation through specialized expertise and commission-based revenue that supports sustainable growth and customer relationship development. The company completed its public offering on 2025-02-19, accessing capital markets during evolving industry dynamics within the Medical Instruments & Supplies landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to surgical instrument innovation as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated strong market reception and sustained investor interest reflecting confidence in growth strategy execution. Market assessment focuses on the company's training efficiency and strategic emphasis on respiratory care equipment as indicators of long-term competitive positioning within the Medical Instruments & Supplies sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires July 31, 2025, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on surgical instrument innovation and emphasis on cost-effective solutions, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Medical Instruments & Supplies market landscape.

Performance Overview

Since going public at $5.00 per share on Feb 19, 2025, Anbio Biotechnology shares have gained 456.2%, rewarding investors who participated in the IPO. The stock currently trades at $27.81, giving the company a market capitalization of $1.2B.

Lockup Expiration

The lockup period for Anbio Biotechnology expired 254 days ago on Aug 18, 2025. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

Anbio Biotechnology operates in the Medical Instruments & Supplies sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing NNNN as an investment.

Trading History

Anbio Biotechnology is actively trading in the public markets with a current share price of $27.81. The company went public at $5.00 per share, resulting in gains of 456.2% for IPO investors. With a current market capitalization of $1.2B, Anbio Biotechnology continues to establish its presence as a publicly traded entity in the Medical Instruments & Supplies.

Important Disclaimer

This analysis of Anbio Biotechnology (NNNN) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

3

Pre-Expiry Average

Minimal

87

Expiry Day

Very High

56

Post-Expiry (30d)

High

Activity Heatmap

60 days before/after lockup expiry

Intensity Scale:

Minimal

Low

Moderate

High

Very High

Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Similar IPOs

Companies with similar industry, market cap, or IPO timing

KMTS

Kestra Medical Technologies, Ltd.

+27.4%

return

Industry:

Medical Instruments & Supplies

Same IndustrySame ExchangeSimilar Size

AVR

Anteris Technologies Global Corp.

-5.3%

return

Industry:

Medical Instruments & Supplies

Same IndustrySame Exchange

CUPR

Cuprina Holdings (Cayman) Limited

-92.9%

return

Industry:

Medical Instruments & Supplies

Same IndustrySame Exchange

Medical Instruments & Supplies

Same IndustrySame Exchange

ZJYL

Jin Medical International Ltd.

-71.3%

return

Industry:

Medical Instruments & Supplies

Same IndustrySame Exchange

Medical Instruments & Supplies

Same IndustrySimilar Size

Want to compare these IPOs side by side?

Compare Tool →

Related IPOs

Ticker	Company	Industry	IPO Date	IPO Price	Current	Return
BTTC	Black Titan Corp	Services-Computer Programming Services	Dec 23, 2025	$1.31	$1.30	-0.8%
ANDG	Andersen Group Inc.	Personal Services	Dec 17, 2025	$16.00	$35.59	+122.4%
MDLN	Medline Inc.	Medical Instruments & Supplies	Dec 17, 2025	$29.00	$44.24	+52.5%
STI	Solidion Technology Inc.	Miscellaneous Electrical Machinery, Equipment & Supplies	Dec 15, 2025	$4.45	$4.33	-2.7%
WLTH	Wealthfront Corporation	Software - Application	Dec 12, 2025	$14.00	$10.71	-23.5%
LMRI	Lumexa Imaging Holdings, Inc.	Medical Devices	Dec 11, 2025	$18.50	$9.34	-49.5%
CDNL	Cardinal Infrastructure Group Inc.	Engineering & Construction	Dec 10, 2025	$21.00	$48.93	+133.0%
JMG	JM Group Limited	Specialty Retail	Dec 10, 2025	$4.00	$6.61	+65.3%